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ScienceDirectStructure-based prediction of protein allostery
Joe G Greener and Michael JE SternbergAllostery is the functional change at one site on a protein
caused by a change at a distant site. In order for the benefits of
allostery to be taken advantage of, both for basic
understanding of proteins and to develop new classes of drugs,
the structure-based prediction of allosteric binding sites,
modulators and communication pathways is necessary. Here
we review the recently emerging field of allosteric prediction,
focusing mainly on computational methods. We also describe
the search for cryptic binding pockets and attempts to design
allostery into proteins. The development and adoption of such
methods is essential or the long-preached potential of allostery
will remain elusive.Address
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Introduction
Allostery in its broadest sense is the functional change at
one site on a protein caused by a change at a distant site.
The perturbation at the allosteric site can be non-covalent
binding of a molecule (e.g. small molecule, ions, RNA,
DNA), covalent binding (e.g. phosphorylation) or light
absorption [1]. Changes in structure or dynamics lead to
effects such as a reduction or increase in catalytic activity,
changes in disordered regions or changes in oligomerisa-
tion state.
Since the first discovery of allosteric systems more than
50 years ago there have been various models put forward
to describe the phenomenon. The dominant proposals
for many years were the Monod-Wyman-Changeux
(MWC) model, which posited that pre-existing states
are subject to an equilibrium shift on modulator binding,
and the Koshland–Ne´methy–Filmer (KNF) model,
which advanced the idea that there was an induced fit
of a binding site on interaction with a modulator [2 [2_TD$DIFF] .www.sciencedirect.comThe structural view of allostery, which aimed to elucidate
the allosteric mechanism by finding structural changes on
effector binding, began to fill the gaps left by the
phenomenological MWC and KNF descriptions. The
discovery that entropic contributions to allostery can be
significant predicted the phenomenon of allostery with-
out conformational change, where the allosteric effect is
communicated by a change in protein dynamics rather
than protein structure [2].
More recently these views on allostery have been revis-
ited and reconciled in approaches that focus on the
ensemble of conformational states that proteins exist in
[2,3]. Figure 1 outlines the current understanding of
allostery. A perturbation at any site in the structure leads
to a shift in the occupancy of states by the population, so
allostery is a property of the conformational ensemble.
The effect at the allosteric site is linked to the active site
by small conformational changes that transmit the allo-
steric effect in a wave-like manner along pathways of
amino acids in the protein [4]. These pathways may be
conserved by evolution. It is also important to consider
the effect of allostery on cellular networks and reaction
pathways [1], with allosteric effects propagating via pro-
tein-protein interactions.
Allosteric drugs have hardly been explored and holdmany
potential benefits over orthosteric (non-allosteric) drugs:
they are highly specific as they do not bind to active sites
that are often conserved in protein families; they can
activate as well as inhibit a protein; and they can have a
ceiling to their effect [5]. Allosteric modulators have been
elucidated for targets as diverse as G protein-coupled
receptors (GPCRs), protein kinases, the GABA receptor,
hepatitis C virus polymerase and RNA. Numerous other
allosteric modulators are in various stages of human
clinical trails. However, discovery of allosteric drugs pre-
sents challenges beyond those encountered in orthosteric
drug discovery — see Box 1.
In order to understand and utilise allostery it is necessary
to be able to predict allosteric sites, allosteric modulators
and residues involved in propagating the allosteric signal.
This review outlines advances from the last few years in
the structure-based prediction of protein allostery, largely
focusing on computational approaches. Previous reviews
have covered similar topics [6–9]. The emerging fields of
cryptic allosteric site discovery and allosteric site design
are described. Challenges faced in the structure-based
prediction of allostery and recommended steps for explor-
ing allostery on a protein are also outlined — see Box 1
and Box 2 respectively.Current Opinion in Structural Biology 2018, 50:1–8
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The current conception of allostery. (a) A two-state model of allostery where a protein has an active and an inactive conformation. In the presence
of the allosteric inhibitor the inactive state is favoured either by the inhibitor binding to the protein when it is in the inactive state (red arrow —
conformational selection) or by the inhibitor binding to the active state and causing inactivation (blue arrow — induced fit). (b) The variety of
motions that can lead to allostery. Larger motions or more disorder are shown further down the vertical axis. Figure based on Figure 2 from [2].
(c) A simplified representation of the change in the energy landscape on binding of an allosteric inhibitor. The shaded regions show the main
occupied conformation in each case. On inhibitor binding the relative energies of the active and inactive states are altered. For example,
disruption of a hydrogen bond could destabilise the active state and stabilise the inactive state. (d) Glucokinase, a well-studied example of
allostery [10], is shown as a yellow cartoon. The glucose substrate and the allosteric modulator are shown as spheres coloured by element. The
active site and allosteric site are coloured purple and green respectively.Computational methods
The last few years have seen the emergence of the first
general methods that predict allostery based on protein
structure. Table 1 summarises these methods, many of
which are available as web servers.
Normal mode analysis methods
In normal mode analysis (NMA) the structural fluctua-
tions of a protein around an equilibrium conformation are
decomposed into harmonic orthogonal modes. The long-
range nature of allosteric communication is often well-
described by low-frequency modes that involve the
motion of many atoms. The binding leverage approach
[21] predicts how ligand binding couples to the intrinsicCurrent Opinion in Structural Biology 2018, 50:1–8motions of a protein. Sites with high binding leverage are
predicted to be allosteric. Binding leverage was devel-
oped into the web server SPACER [20], and into the
general predictor STRESS [22] by a different group. The
PARS method [19,18] calculates normal modes in the
presence and absence of a simulated allosteric modulator.
If the motions are significantly different the site is pre-
dicted as allosteric. The AlloPred method [11] calculates
the normal modes of a protein, then holds the springs in
the region of a potential allosteric site rigid and measures
the effect of this perturbation at the active site. The
DynOmics ENM server [15] finds hinge residues that
control the two slowest normal modes of a protein, and
hence are able to influence its dynamics. NMA is suitablewww.sciencedirect.com
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Box 1 Challenges faced in the structure-based prediction of
protein allostery
1 As shown in Figure 1b, an allosteric effect can arise from a variety
of different mechanisms. A general predictor would have to
account for these in a unified manner. This is particularly challen-
ging when disorder is involved, as approaches based on a defined
structure are less applicable. Some approaches to studying dis-
order and allostery have been proposed [71,72].
2 The conformational changes that cause allostery are often large
enough to occur on timescales of microseconds or milliseconds.
This makes them too computationally expensive to study using
MD without the use of accelerated or targeted MD. NMA is more
computationally feasible but the assumption of a harmonic motion
around an energy minimum does not correspond well to two
distinct states with differing conformations.
3 The properties of active site pockets and small molecules that
target the active site have been well-studied, for example Lipins-
ki’s rule of five [73]. Allosteric pockets and modulators may have
generally different properties that we are not yet fully aware of, so
we do not know exactly what to look for [74,75].
4 The effect of an allosteric modulator is difficult to predict and can
range from activation to inhibition, partial or complete. This is in
comparison to orthosteric drug discovery, where drug action is
presumed to be by competitive inhibition at the active site.
5 The effort of researchers and the protein structural data available is
biased towards certain types of protein, such as those relevant in
disease. For example, the allostery of GPCRs has been studied in
detail [76]. There is a lack of protein structural data for important
types of proteins such as membrane proteins and proteins with
significant disorder, but these proteins have considerable potential
to be allosteric [2]. There may be different mechanisms or
approaches to prediction that are relevant to less-studied protein
families. The development of experimental methods such as cryo-
electron microscopy should go some way to resolve this discre-
pancy [77].
Box 2 Recommended steps for predicting and rationalising
allostery on a protein
1 Assemble available structural data from database searches and
homology modelling where appropriate. If possible, obtain differ-
ent conformations of the same protein, for example with or without
an active site inhibitor or known allosteric modulator.
2 Submit structures to available web servers and methods as listed
in Table 1. Explore the output to predict allosteric sites and see
how far results agree.
3 Carry out further computational studies on the protein of interest,
for example MD to investigate conformational changes, changes in
dynamics and communication between sites.
4 Validation of the site experimentally. For example, screen mole-
cules against the site using virtual and/or high-throughput
screening and test hits using crystallography, NMR and activity
studies as appropriate. Site-directed mutagenesis can be used to
validate the binding site and suggested allosteric communication
mechanisms. Use all available data to propose the mechanism of
allostery.for high-throughput, automated approaches as it can be
computationally inexpensive. However whilst NMA-
based methods might be expected to reveal perturbations
to vibrations, the assumption of harmonic fluctuations
around an energetically minimum structure means that
other contributing motions to allostery such as localwww.sciencedirect.comunfolding and rigid body movements [2] are not taken
into account.
Machine learning methods
A few methods have used machine learning to predict
allostery. AlloSite [13] uses a support vector machine and
features from Fpocket [24] to re-rank pockets in terms of
their allosteric character. However the results are often
found to be similar to the Fpocket ranking, showing the
difficulty of distinguishing pockets that have specific
allosteric character from those that are generally suitable
for ligand binding. A Random Forest approach [26] uses
descriptors for binding sites and associated ligands to
assign protein cavities as allosteric, regular or orthosteric.
Molecular dynamics methods
Molecular dynamics (MD) remains the standard compu-
tational tool for structural analysis when structures are
available. A study on the signalling protein NtrC com-
bined MD simulations and NMR data to explore the free
energy landscape and investigate at atomic resolution the
transition from active to inactive state [27]. Perturbation
response scanning (PRS), in which the response of the
structure to random perturbations at specific positions is
examined, is a popular tool for allosteric prediction. For
example, allosteric hotspot residues were predicted using
PRS for the chaperone Hsp70 [28]. Weinkam et al. con-
structed energy landscapes and explored them with MD
[14]. They were able to study the allosteric mechanisms
involved in three proteins. The method is available as the
AllosMod web server.
Evolutionary methods
Classic work has shown that allosteric communication can
be mediated by networks of residues conserved by evo-
lution [29]. One study developed previous work on pro-
tein sectors, groups of co-evolving residues physically
contiguous in structure, to link sector-connected surface
sites to allosteric sites [30]. A recent approach found that
surface and interior critical residues tend to be conserved
[22]. The recent discovery that most directly co-evolving
residues distant in 3D structure are close in related
structures or assemblies [31] brings into question the
concept of allosteric and active sites that directly co-
evolve. As more structural and conservation information
is acquired it will be important to discover to what degree
allostery in proteins is a result of selection on specific
pathways, and to what degree novel allostery can be
discovered on proteins in the absence of previous evolu-
tionary pressure.
Other methods
A recent study [32] constructs an all-atom graph and
calculates for each bond the bond propensity, the strength
of coupling to the active site through the graph. The
method is used to reproduce observed results for three
proteins in detail and is also able to predict allosteric sitesCurrent Opinion in Structural Biology 2018, 50:1–8
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Table 1
Computational allosteric prediction methods currently available to run locally or as a web server, ordered alphabetically. In addition there
are various pocket prediction methods that aim to predict binding pockets on proteins, but not specifically allosteric pockets [23–25]
Name Reference(s) Output(s) Web server available Source code available online
AlloPred [11] Predicted allosteric pockets http://www.sbg.bio.ic.ac.uk/allopred/home Yes, MIT license
AlloSigMA [12] Allosteric free energies http://allosigma.bii.a-star.edu.sg/home No
AlloSite [13] Predicted allosteric pockets http://mdl.shsmu.edu.cn/AST No
AllosMod [14] Modelled energy landscapes http://modbase.compbio.ucsf.edu/allosmod No
ENM method [15] Residues coupled to normal modes http://enm.pitt.edu Partly as ProDy, MIT license
ExProSE [16] Ensemble of protein structures,
predicted allosteric pockets
No Yes, MIT license
MCPath [17] Allosteric communication pathways http://safir.prc.boun.edu.tr/clbet_server No
PARS [18,19] Predicted allosteric pockets http://bioinf.uab.cat/pars No




STRESS [22] Predicted surface-critical and
interior-critical residues
No Yesin a dataset of 20 allosteric proteins. ExProSE [16] takes
two structures of the same protein and generates an
ensemble of structures using distance constraints. By
adding extra constraints at a possible allosteric site, a
perturbed ensemble is generated. By comparing ensem-
bles with and without the allosteric perturbation, alloste-
ric sites can be predicted and the effect of perturbation on
structure and dynamics can be explored. This work also
includes a quantitative comparison of available allosteric
site prediction methods.
Methods not specific to allostery
The identification of binding sites on the protein surface
is a problem that has long pre-dated the search for pockets
that are specifically allosteric. These methods are how-
ever useful in the structure-based prediction of allo-
stery — the identification of a high-affinity binding site
distant from a known active site could present an oppor-
tunity for allosteric regulation, for example. The FTMap
family of web servers [33] predicts ligand-binding hot-
spots using small organic molecules as probes on the
protein surface. By using mixed-solvent MD this princi-
ple has been extended to the prediction of allosteric sites
in particular, with success on some test cases [34]. Com-
mon pocket prediction methods such as LIGSITEcsc [23]
and Fpocket [24] are able to find pockets on a protein
large enough to bind small molecules, and these often
correspond to allosteric sites [16].
Allosteric pathway prediction
Allosteric signals can be propagated by multiple commu-
nication pathways [4]. Understanding these pathways is
necessary in order to predict sites that are able to com-
municate with the active site [35]. A machine learning
approach to predict residues involved in allosteric com-
munication uses a variety of structural and network fea-
tures and is able to predict these hotspots with reasonable
accuracy [36]. A different approach, McPath, uses a
Monte Carlo algorithm to define likely allostericCurrent Opinion in Structural Biology 2018, 50:1–8pathways by examining inter-residue interactions in a
residue network [17]. A study that added an allosteric
domain to a protein analysed residue contact maps to find
loops mechanically coupled to the active site [37]. An
investigation on the PDZ domain using MD found
that allosteric changes are non-linear and occur in a
non-local fashion, and are similar in many ways to protein
folding [38].
Experimental methods
Experimental studies such as crystallography, NMR and
site-directed mutagenesis remain the best tools for
exploring allostery in a particular protein. A synthetic
azetidine derivative that kills Mycobacterium tuberculo-
sis (Mtb) through allosteric inhibition of tryptophan
synthase (TrpAB), a previously untargeted enzyme,
was found by a high-throughput screen [39]. The inhi-
bition is not easily overcome by changes in metabolic
environment due to the modulator binding at the TrpAB
a-b-subunit interface and affecting multiple steps in
the overall reaction of the enzyme. A study on the
proteasome [40] crystallised the complex in the presence
and absence of an allosteric modulator. Having the
active and inactive structures allowed the authors to
propose a detailed mechanism of inactivation, which
has implications for future allosteric proteasome inhibi-
tors. A study on flavovirus protease [41] used a virtual
screen to select 29 potential allosteric compounds that
were tested experimentally. One showed an ability to
inhibit the conformational change and also inhibit flavo-
virus growth. Allosteric pathways in ERG proteins were
proposed using fluctuation correlation data and validated
by mutating residues in the pathways [42]. However,
there are limits to the use of mutational studies to validate
allosteric mechanisms. It has been found that mutational
data can give evidence for a deliberately poorly conceived
allosteric mechanism [43]. In the future it is to be hoped
that experimental screens specifically for allosteric siteswww.sciencedirect.com
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conventional large-scale screens for allosteric drugs.
Cryptic allosteric sites
The discovery of cryptic binding pockets — pockets that
are only available in some conformations of the protein
and may not have an associated experimental struc-
ture — has the potential to vastly increase the number
of druggable sites on proteins [49] and is directly relevant
to allosteric prediction. A recent study [50] showed using
NMR data that ligands of the LpxC enzyme access a
cryptic site that is invisible to crystallography. One study
usedMarkov state modelling andMD to predict multiple
hidden allosteric sites on b -lactamase and tested these
using thiol labelling experiments [51], later finding mod-
ulators for the sites [52]. The general approach CryptoSite
uses machine learning to predict cryptic pockets on
proteins using sequence and structural features [25].
However, two problems affect the use of cryptic allosteric
pockets over allosteric sites where the pocket is present in
most or all conformations. Firstly, the shape of the pocket
is not known so rational drug design is difficult. Secondly,
there is potentially an energetic cost associated with
the protein adopting the conformation required for the
cryptic pocket [53]. However, the discovery of ligands
with inhibition constants in the low picomolar range in
the above study [50] show that these sites are druggable.
Further computational and experimental studies are
required to explore this promising area.
Design of allosteric sites
The rational design of allosteric sites is a problem closely
related to structure-based prediction of allostery. Intro-
ducing allosteric sites into existing proteins, or creating
fusion proteins to add activity switches, has many poten-
tial applications including in biotechnology [54]. A recent
study added a PDZ domain into the Cas9 protein at a site
that did not disrupt enzyme action [55]. The protein
showed modulator-dependent activity in cells, establish-
ing a system for Cas9 activation. Another study created
fusion proteins that use conformational entropy to
respond to temperature or pH as a switch [56]. Taylor
et al. engineered Escherichia coli LacI to respond to one of
four new inducer molecules using computational design
and mutagenesis [57]. Dagliyan et al. designed a protein
with a unique topology, uniRapR, whose conformation is
controlled by the binding of a small molecule [58]. The
switching and control ability of uniRapRwas confirmed in
silico, in vitro, and in vivo. uniRapR was used as an
artificial regulatory domain to control activity of kinases
as a proof of concept. The same group built on this and
inserted the light-sensitive LOV2 domain into 3 proteins
at non-conserved, surface-exposed loops identified com-
putationally using residue contact analysis as being allo-
sterically coupled to active sites [37].www.sciencedirect.comDiscussion
It is challenging to compare different methods for allo-
steric prediction. The different inputs and, more com-
monly, outputs make systematic comparisons difficult.
One quantitative comparison indicated broadly similar
performance between four available methods [16]. One of
the Critical Assessment of Genome Interpretation chal-
lenges in 2015–16 focused on predicting the influence of
mutations on the allosteric regulation of human liver
pyruvate kinase [59]. However the uptake was limited
to four groups and the predictive ability was marginally
better than random. In the long run a dedicated commu-
nity-wide initiative similar to the Critical Assessment of
Structure Prediction [60] would be beneficial to the field
of allosteric prediction.
One factor holding allosteric prediction back is the lack of
a varied and robust set of benchmarks to test methods
against. ASBench [61] is a curated set of allosteric pro-
teins, and has been used for example to benchmark
AlloPred [11]. It is a subset of the AlloSteric Database
(ASD) [62]. ASD v3.0 contains over 1400 proteins and also
includes allosteric mechanisms, allosteric networks of
proteins and ‘allosteromes’ of the allostery involved in
protein kinases and GPCRs. Improvements in such
resources are necessary to prevent the developers of
new methods having to assemble their own datasets
[19,21,32] and to allow systematic comparisons between
methods.
An issue that requires more study in the field of allosteric
prediction is the exact relationship between an allosteric
modulator and whether it acts as an activator or inhibitor.
It has been shown that under different conditions the
same allosteric modulator can have opposite effects [63].
Another viewpoint is the anchor/driver model of allostery,
with the concept of a pushing or pulling driver determin-
ing which way the ligand acts [64]. An approach to study
this would be a quantitative structure activity relation-
like study where a variety of modulators and conditions
are explored on the same protein. This would give evi-
dence as to whether small structural differences causing a
pushing or pulling effect are enough to reliably switch
activator/inhibitor action.
Themechanism of dynamic allostery, where the allosteric
effect is transmitted through changes in dynamics and the
average structure does not necessarily change, also
requires further investigation. While experimental stud-
ies [65,66,39] have found evidence for dynamic allo-
stery, Nussinov and Tsai [67] warn that an apparent lack
of conformational change can be an artefact of various
factors such as crystal packing, crystallisation conditions,
disorder to order transitions, incremental activation, syn-
ergy between allosteric sites and changes in oligomeric
state. A recent MD study proposes that allostery in the
well-studied PDZ domain is driven by changes inCurrent Opinion in Structural Biology 2018, 50:1–8
6 Sequences and topologyelectrostatic effects rather than solely changes in dynam-
ics [68,69]. The role of water in allostery also needs to be
further explored as evidence has been found that re-
arrangement of water molecules is a possible mechanism
of allostery [70,32].
Conclusion
For many years papers have pointed to the immense
potential of allostery for both understanding and drugging
proteins. Yet they regularly contain the qualification that a
unified framework of allostery remains ‘elusive’, and
approved allosteric drugs remain rare more than 50 years
after the first descriptions of allostery. In order to unlock
the dormant potential of allostery, predictive methods
need to be as established and robust as those in other
areas of bioinformatics. When allosteric prediction is as
effective as prediction of secondary structure or disor-
dered regions, the power of allostery will be truly
revealed. In an analogous way to allostery itself, it is
hoped that the effects of exploring allostery will propa-
gate to all areas of structural biology.
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